PTEN in the haematopoietic system and its therapeutic indications
| Autor: | Alison M. Cheung, Tak W. Mak |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Phosphatase
Biology Models Biological law.invention Mice law Tensin PTEN Animals Molecular Biology PI3K/AKT/mTOR pathway Sirolimus Leukemia TOR Serine-Threonine Kinases PTEN Phosphohydrolase Genetic Therapy Hematopoietic Stem Cells Haematopoiesis Immunology Cancer research biology.protein Neoplastic Stem Cells Molecular Medicine Suppressor Stem cell Protein Kinases Signal Transduction |
| Zdroj: | Trends in molecular medicine. 12(11) |
| ISSN: | 1471-4914 |
| Popis: | A unique feature of the haematopoietic system is its self-renewal ability while maintaining a stable number of pluripotent haematopoietic stem cells (HSCs). Recently, two publications by Yilmaz and colleagues and Zhang and colleagues demonstrated that the loss of the tumour suppressor phosphatase and tensin homolog (PTEN) in mice disturbed the maintenance of quiescent HSCs and promoted leukemogenesis. Mammalian target of rapamycin (mTOR) inhibition with rapamycin distinctly rescued HSC development and depleted leukemic stem cells. Thus, the regulation of HSCs and leukemic cells seems to be governed by cell-context-dependent, PTEN-mediated regulation of mTOR. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect